EPS

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

With its burn treatment gaining traction and a pivotal wound care drug in late-stage trials, MediWound prepares to make its case to Wall Street.

Valmont Industries posts strong adjusted Q4 earnings, banking on a booming infrastructure segment to counter a deep agricultural slump and fuel growth in 2026.

As Xtract One readies its Q2 results, investors eye its booming backlog against a backdrop of rising competition and ethical questions in AI security.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

After a year of major acquisitions and divestitures, the packaging giant posts surging profits and outlines a simplified, focused strategy for 2026.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

LP's 7% dividend hike reflects strong financials and a cautiously optimistic outlook for the evolving construction and housing markets in 2026.

Tacoma-based Columbia Banking System holds its quarterly dividend at $0.37, reflecting strong earnings and strategic growth in a complex regional market.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

Essent Group boosts its dividend after a strong 2025, returning $700M to shareholders while making a strategic leap into the global P&C reinsurance market.

The global lighting leader will repurchase 725,000 shares, a strategic move to cover employee incentives, manage dilution, and signal financial health.

Capgemini's 2025 results show a strong pivot to AI, with bookings soaring and a €700M plan to reshape its workforce for a new era of tech.

With strong financials and a focus on tech, Allegion's CEO will outline the security giant's long-term strategy for a digitally connected world.

With top executives set for major conferences, investors eye Mastercard's playbook for commercial payments and Americas growth amid fierce competition.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

With revolutionary tech and a volatile stock, PureCycle's year-end update is a critical test of its operational progress and financial promises.

As Perimeter preps its year-end results, investors are watching if its aggressive diversification can overcome operational hurdles and justify its new shape.

The retail REIT reports record-breaking leasing and strong profits for 2025, while executing a strategic portfolio overhaul and setting a confident tone for 2026.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.